← All themes
Pharmaceuticals stocks
제약
What are Pharmaceuticals stocks in Korea?
The Pharmaceuticals theme on jonbur groups 110 Korean stocks listed on KOSPI and KOSDAQ, worth ₩175T in total. On Oct 30, 2026 the group moved up 3.61% (weighted by market value); the largest members are Samsung Biologics, Celltrion, Alteogen.
Key facts
- Stocks
- 110
- Total market value
- ₩175T
- Day's move
- +3.61%
- As of
- Oct 30, 2026
- Largest members
- Samsung Biologics, Celltrion, Alteogen
Earnings tracker · 3Q 2025
Past quarter
98 of 102 reportedOperating profit up vs a year ago: 52 of 95
Revenue+11.0%
Operating profit+54.4%
Net profit+182.9%
Combined, for the companies that have reported, vs the same quarter a year ago
| Company | Reported | Revenue | vs a year ago | Operating profit | vs a year ago | vs last quarter | Op. margin |
|---|---|---|---|---|---|---|---|
| Samsung Biologics | Nov 14 | ₩1.7T | +39.9% | ₩729B | +115.3% | +53.2% | 43.9%28.5% |
| Celltrion | Nov 14 | ₩1T | +16.7% | ₩301B | +45.1% | +24.3% | 29.3%23.5% |
| Alteogen | Nov 14 | ₩49B | +902.3% | ₩27B | Turned to profit | Turned to profit | 54.4%−166.8% |
| Yuhan | Nov 14 | ₩570B | −4.8% | ₩22B | −53.7% | −55.8% | 3.9%7.9% |
| HLB | Nov 14 | ₩22B | +30.4% | −₩23B | Bigger loss | Smaller loss | −104.1%−115.4% |
| Hanmi Pharm | Nov 14 | ₩362B | +0.1% | ₩55B | +8.0% | −8.9% | 15.2%14.1% |
| SAM Chun Dang Pharm | Nov 14 | ₩58B | +10.8% | ₩3.4B | Turned to profit | Turned to profit | 5.9%−1.6% |
| Hanmi Science | Nov 14 | ₩343B | +6.2% | ₩39B | +75.2% | +13.5% | 11.5%7.0% |
| D&D Pharmatech | Nov 14 | ₩969M | −50.0% | −₩6.2B | Smaller loss | Smaller loss | −640.5%−360.3% |
| ST Pharm | Nov 14 | ₩82B | +32.7% | ₩15B | +141.6% | +14.0% | 18.0%9.9% |
| Daewoong Pharma | Nov 14 | ₩412B | +14.9% | ₩57B | +52.6% | −1.7% | 13.8%10.4% |
| DongKook Pharmaceutical | Nov 14 | ₩227B | +12.9% | ₩25B | +10.1% | +12.0% | 10.9%11.2% |
| HK inno.N | Nov 14 | ₩261B | +13.7% | ₩26B | +16.4% | +32.5% | 9.9%9.7% |
| Daewoong | Nov 14 | ₩542B | +5.1% | ₩81B | −20.8% | −5.6% | 14.9%19.7% |
| Chong Kun Dang Pharmaceutical | Nov 14 | ₩430B | +4.1% | ₩21B | −19.4% | −11.2% | 4.9%6.3% |
| SK Chemicals | Nov 13 | ₩610B | +43.1% | ₩16B | Turned to profit | Turned to profit | 2.6%−2.9% |
| Boryung | Nov 14 | ₩280B | +3.3% | ₩29B | +51.3% | +16.0% | 10.5%7.2% |
| Komipharm International | Nov 14 | ₩12B | +13.6% | ₩66M | −92.7% | −96.0% | 0.5%8.2% |
| Dong-A Pharmaceutical | Nov 14 | ₩383B | +7.2% | ₩33B | +47.7% | +18.3% | 8.7%6.3% |
| JW Pharmaceutical | Nov 14 | ₩200B | +12.0% | ₩32B | +20.7% | +28.3% | 16.0%14.9% |
| Shinpoong Pharmaceutical | Nov 14 | ₩63B | +12.2% | ₩7.2B | Turned to profit | +46.2% | 11.5%−0.3% |
| GC | Nov 14 | ₩737B | +20.8% | ₩26B | −24.5% | +20.0% | 3.5%5.7% |
| IL Dong Pharmaceutical | Nov 13 | ₩145B | −6.7% | ₩6.8B | +87.6% | +1,033.9% | 4.6%2.3% |
| T&L | Nov 14 | ₩41B | −16.5% | ₩12B | −31.9% | +21.8% | 29.8%36.6% |
| Bukwang Pharmaceutical IND | Nov 14 | ₩48B | +12.2% | ₩979M | −69.2% | −51.4% | 2.0%7.5% |
| Dong-A ST | Nov 14 | ₩216B | +12.8% | ₩14B | +221.9% | Turned to profit | 6.5%2.3% |
| Kwangdong Pharmaceutical | Nov 14 | ₩445B | +4.7% | ₩11B | +692.4% | +139.3% | 2.4%0.3% |
| Korea United Pharm | Nov 13 | ₩74B | +4.3% | ₩13B | −16.9% | +16.3% | 16.8%21.1% |
| Samyang NC Chem | Nov 13 | ₩29B | — | ₩4.1B | — | −5.4% | 14.2% |
| Huons Global | Nov 14 | ₩211B | +5.9% | ₩20B | +41.6% | −19.5% | 9.6%7.2% |
| Samjin Pharmaceutical | Nov 14 | ₩83B | +3.2% | ₩9.8B | +6.3% | +22.9% | 11.8%11.4% |
| Humedix | Nov 14 | ₩41B | +9.5% | ₩9B | −2.9% | −16.9% | 21.9%24.7% |
| Ilsung IS | Nov 14 | ₩17B | −11.9% | −₩845M | Turned to loss | Smaller loss | −5.0%4.6% |
| Hyundai Pharmaceutical | — | ₩52B | +11.6% | ₩3.5B | Turned to profit | +220.6% | 6.7%−0.9% |
| Huons | Nov 14 | ₩154B | +4.7% | ₩9.9B | +13.7% | −24.4% | 6.4%5.9% |
| Daewon Pharmaceutical | — | ₩144B | −8.2% | −₩10B | Turned to loss | Bigger loss | −7.2%7.3% |
| Whanin Pharm | Nov 13 | ₩66B | −3.5% | ₩3.6B | −32.8% | +31.6% | 5.4%7.8% |
| Union Korea Pharm | Nov 14 | ₩7.1B | −54.8% | −₩9.9B | Bigger loss | Bigger loss | −139.0%−12.3% |
| HEM Pharma | Nov 28 | ₩3B | −8.3% | −₩3.6B | Bigger loss | Bigger loss | −120.4%−69.1% |
| Vivozon Pharmaceutical | Nov 10 | ₩6.8B | −71.4% | −₩10B | Turned to loss | Bigger loss | −151.0%5.4% |
| GC WellBeing | Nov 14 | ₩42B | +28.0% | ₩5.2B | +32.8% | +23.5% | 12.3%11.9% |
| Chongkundang Holdings | Nov 14 | ₩234B | +0.9% | ₩18B | +142.4% | +9.7% | 7.7%3.2% |
| Reyon Pharmaceutical | Nov 14 | ₩38B | −1.9% | −₩7.2B | Turned to loss | Smaller loss | −19.2%4.3% |
| Dongsung Chemical | Nov 14 | ₩315B | +23.9% | ₩34B | +65.3% | +28.9% | 10.9%8.1% |
| DAE HWA Pharm | Nov 14 | ₩37B | +2.6% | ₩1B | −37.5% | +267.8% | 2.9%4.7% |
| Yungjin Pharm | Nov 14 | ₩61B | −1.9% | ₩3.6M | −99.7% | −99.8% | 0.0%2.1% |
| JW Lifescience | Nov 14 | ₩63B | +8.0% | ₩7.1B | −23.8% | −24.6% | 11.3%16.0% |
| Samil Pharmaceutical | Nov 14 | ₩51B | −4.0% | −₩5.2B | Bigger loss | Bigger loss | −10.1%−0.4% |
| Kyungdong Pharm | Nov 14 | ₩49B | −1.5% | ₩3.1B | +484.3% | +545.6% | 6.3%1.1% |
| Daehan Pharmaceutical | Nov 14 | ₩56B | +2.4% | ₩11B | −1.8% | +37.3% | 18.9%19.7% |
| Hana Pharm | Nov 14 | ₩64B | +11.4% | ₩8.3B | +114.6% | +38.4% | 13.1%6.8% |
| Dongwha Pharm | Nov 14 | ₩122B | +10.7% | ₩1.4B | Turned to profit | +123.1% | 1.1%−0.5% |
| Ilyang Pharmaceutical | Nov 13 | ₩69B | −30.6% | −₩158M | Turned to loss | Turned to loss | −0.2%5.5% |
| Jeil Pharmaceutical | Nov 14 | ₩135B | −22.7% | ₩9.8B | Turned to profit | +109.7% | 7.3%−2.3% |
| Ahn-Gook Pharmaceutical | Nov 14 | ₩78B | +15.1% | ₩4.9B | +590.2% | −1.6% | 6.3%1.0% |
| Kyongbo Pharmaceutical | Nov 14 | ₩67B | +15.0% | ₩474M | −85.0% | −80.3% | 0.7%5.4% |
| Dongsung Pharmaceutical | Nov 14 | ₩22B | +1.7% | ₩411M | Turned to profit | Turned to profit | 1.9%−3.3% |
| Samsung Pharmaceutical | Nov 14 | ₩12B | +8.3% | −₩3.9B | Bigger loss | Smaller loss | −32.1%−32.6% |
| Handok | Nov 14 | ₩145B | +12.1% | ₩182M | Turned to profit | −16.6% | 0.1%−2.4% |
| Kukjeon | Nov 13 | ₩29B | −6.7% | −₩2B | Bigger loss | Bigger loss | −7.0%−0.0% |
| Jeil Pharma Holdings | Nov 14 | ₩161B | −15.1% | ₩18B | Turned to profit | +161.1% | 11.2%−1.7% |
| Optus Pharmaceutical | Nov 14 | ₩24B | +24.7% | ₩3.2B | +153.3% | +4.8% | 13.4%6.6% |
| Icure Pharmaceutical Incorporation | Nov 14 | ₩25B | +59.8% | −₩3.3B | Smaller loss | Smaller loss | −13.0%−28.0% |
| DongKoo Bio & Pharma | Nov 14 | ₩62B | −6.3% | ₩2.2B | −68.9% | +13.4% | 3.5%10.6% |
| High Tech Pharm | Nov 14 | ₩18B | +5.6% | ₩3.9B | +5.2% | +21.4% | 21.9%22.0% |
| Prestige Biologics | Nov 14 | −₩3.2B | Bigger loss | −₩6.2B | Smaller loss | Smaller loss | — |
| Sam-A Pharm | Nov 13 | ₩15B | −27.9% | −₩1.1B | Turned to loss | Turned to loss | −7.4%7.4% |
| Korea Pharma | Nov 14 | ₩24B | +24.8% | ₩507M | −53.8% | +514.5% | 2.1%5.7% |
| Withus Pharmaceutical | Nov 14 | ₩27B | −1.4% | ₩1.4B | −31.8% | +65.0% | 5.0%7.3% |
| Polaris AI Pharma | Nov 14 | ₩15B | +4.0% | ₩1.6B | +101.7% | +23.3% | 10.7%5.5% |
| Daehan Nupharm | Nov 13 | ₩49B | +0.2% | ₩2.1B | −48.8% | −32.0% | 4.3%8.3% |
| Shinil Pharmaceutical | Nov 13 | ₩21B | 0.0% | ₩2.7B | −11.2% | −15.8% | 12.9%14.6% |
| Daebonglsco | Nov 14 | ₩25B | +2.5% | ₩768M | −75.7% | −67.3% | 3.1%13.0% |
| SY Dong-A | Nov 14 | ₩102B | +4.3% | ₩5.6B | +3.1% | +3.1% | 5.5%5.6% |
| Samik Pharm | Nov 14 | ₩16B | — | ₩1.1B | — | — | 6.8% |
| Kukje Pharma | Nov 14 | ₩46B | +15.1% | ₩1.9B | +14.1% | −45.4% | 4.2%4.2% |
| Ildong Holdings | Nov 13 | ₩144B | −13.4% | ₩6.1B | +5,729.2% | Turned to profit | 4.2%0.1% |
| CMG Pharmaceutical | Nov 13 | ₩30B | +23.0% | ₩1.2B | +798.4% | Turned to profit | 4.0%0.5% |
| Sinsin Pharmaceutical | Nov 14 | ₩30B | +11.7% | ₩4B | +111.7% | +78.2% | 13.1%6.9% |
| Yuyu Pharma | Nov 14 | ₩38B | +12.5% | ₩5B | +41.7% | +122.0% | 13.2%10.5% |
| GL Pharm Tech | Nov 10 | ₩9.5B | +103.7% | ₩253M | +82.5% | +39.1% | 2.6%3.0% |
| CJ Bioscience | Nov 14 | ₩738M | −0.8% | −₩6.1B | Smaller loss | Smaller loss | −823.7%−1,150.7% |
| JIN Yang Pharmaceutical | Nov 14 | ₩29B | −7.5% | −₩940M | Turned to loss | Turned to loss | −3.2%13.8% |
| Hwail Pharm | Nov 13 | ₩24B | −17.9% | ₩165M | +17.8% | +224.4% | 0.7%0.5% |
| BL Pharmtech | Nov 14 | ₩907M | −64.6% | −₩503M | Bigger loss | Smaller loss | −55.4%−4.1% |
| Myungmoon Pharm | Nov 14 | ₩50B | +6.1% | ₩454M | −49.7% | −92.0% | 0.9%1.9% |
| Kyung NAM Pharm | Nov 14 | ₩14B | −1.7% | −₩1.1B | Bigger loss | Bigger loss | −7.5%−0.6% |
| Korean Drug | Nov 14 | ₩16B | −3.1% | ₩2B | −32.9% | −11.6% | 12.0%17.3% |
| Bcworldpharm | Nov 14 | ₩19B | +9.9% | ₩148M | −55.7% | −91.9% | 0.8%1.9% |
| Korea Arlico Pharm | Nov 14 | ₩52B | +6.9% | ₩4M | −99.7% | −99.8% | 0.0%2.6% |
| Tdspharm | Nov 14 | ₩8.1B | — | ₩1.6B | — | +407.3% | 20.3% |
| Poongjeon Pharmacy | Nov 13 | ₩320M | +87.8% | −₩1.1B | Smaller loss | Bigger loss | −357.2%−1,784.8% |
| Wooyang | Nov 14 | ₩48B | +5.3% | ₩982M | Turned to profit | +2.8% | 2.0%−1.4% |
| Seoul Pharma | Nov 14 | ₩14B | +1.8% | −₩34M | Turned to loss | Smaller loss | −0.2%0.5% |
| Telcon RF Pharmaceutical | Nov 14 | ₩9.8B | +37.2% | −₩8.7M | Smaller loss | Smaller loss | −0.1%−17.3% |
| Jeonjinbio | Nov 14 | ₩4.5B | −15.2% | ₩326M | −35.2% | +277.6% | 7.3%9.6% |
| ChoA Pharmaceutical | Nov 14 | ₩15B | +1.6% | −₩1.5B | Smaller loss | Smaller loss | −9.6%−17.7% |
| Kmpharmaceutical | Nov 14 | ₩4.4B | +32.7% | −₩809M | Bigger loss | Bigger loss | −18.5%−22.8% |
| Myungin Pharm | Not yet | ||||||
| Pharmaresearch Bio | Not yet | ||||||
| Imgt | Not yet | ||||||
| BASKHANBIOPharma | Not yet | ||||||
Single-quarter figures. Preliminary figures are the company's own early numbers and are replaced by the quarterly report when it's filed. Expected dates are around when each company reported a year ago.
Technical breadth
After the close on Oct 30, 2026- Above 20-day average
- 6.7%
- Above 60-day average
- 14.3%
- RSI above 70
- 0%
- RSI below 30
- 22.9%
- 52-week highs
- 0
- 52-week lows
- 16
Index gauge · Short term
Bearish
0 bullish, 2 neutral, 7 bearish
Index gauge · Medium term
Bearish
0 bullish, 0 neutral, 8 bearish
Technical read
The Pharmaceuticals theme has 105 members, and only 6.7% of them trade above their 20-day average while 14.3% sit above their 60-day average. No member is currently at a 52-week high, and 16 are at 52-week lows, with the lowest RSI reading at 22.9 and no member showing an RSI reading at the high end. The equal-weighted index gauge is bearish on both short and medium horizons, with its RSI at 31.3 and the index positioned below its cloud.
Written by AI from the indicator values above. Not advice.
Share of members, from each member's own indicators; the gauge reads an equal-weighted index of the members. Technical indicators describe past price and volume patterns. They are not predictions or recommendations.
Credit & macro
- MaturitiesOct 22, 202675Boryung: ₩86bn of bonds due in the next 6 months vs ₩50bn cash₩86bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.Boryung
- MaturitiesOct 20, 202685SK Reit: ₩130bn of bonds due in the next 6 months vs ₩54bn cash₩350bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2025 FY.SK ReitSK hynixSK NetworksSK DiscoverySKCSK Telecom
Creators talking about this
Pharmaceuticals
−0.62%제약
The pharmaceuticals theme in Korea covers companies that develop, manufacture, and sell prescription drugs, generic medicines, and over-the-counter products, along with some firms focused on contract drug manufacturing and biosimilars. Korean investors often group these companies together because they share regulatory frameworks, drug approval processes, and sensitivity to healthcare policy such as national insurance pricing decisions. The theme is also closely watched for research pipeline news, export deals, and clinical trial results.
110 companies · 30 up · 8 flat · 72 down
- Traded value
- ₩602B
- Value vs 20-day average
- 0.99×
- Top gainer
- Daewon Pharmaceutical +12.73%
- Largest company
- Samsung Biologics ₩69T
Companies in this theme
| Company | Price | Daily | Traded value | Market cap | NPS |
|---|---|---|---|---|---|
Samsung Biologics207940 · KOSPI | ₩1,487,000 | +8.86% | ₩144B | ₩69T | 6.88% |
Celltrion068270 · KOSPI | ₩191,600 | +1.22% | ₩100B | ₩44T | 7.28% |
Alteogen196170 · KOSDAQ | ₩211,500 | −3.86% | ₩71B | ₩15T | 2.68% |
Yuhan000100 · KOSPI | ₩75,100 | +0.54% | ₩20B | ₩5.5T | 6.83% |
HLB028300 · KOSDAQ | ₩40,000 | +0.76% | ₩30B | ₩5.3T | 1.16% |
Hanmi Pharm128940 · KOSPI | ₩415,000 | +6.82% | ₩103B | ₩5.3T | 9.61% |
SAM Chun Dang Pharm000250 · KOSDAQ | ₩182,700 | −3.13% | ₩15B | ₩4.3T | 1.34% |
Hanmi Science008930 · KOSPI | ₩43,100 | +2.13% | ₩13B | ₩2.9T | 6.27% |
D&D Pharmatech347850 · KOSDAQ | ₩40,850 | −2.04% | ₩20B | ₩1.9T | 1.75% |
ST Pharm237690 · KOSDAQ | ₩72,500 | −2.03% | ₩8.5B | ₩1.5T | 5.77% |
Daewoong Pharma069620 · KOSPI | ₩101,100 | −0.39% | ₩3.1B | ₩1.2T | 10.30% |
DongKook Pharmaceutical086450 · KOSDAQ | ₩23,450 | −1.88% | ₩7.6B | ₩1.1T | 3.33% |
HK inno.N195940 · KOSDAQ | ₩34,250 | −1.15% | ₩3B | ₩970B | 5.03% |
Daewoong003090 · KOSPI | ₩15,110 | +1.41% | ₩934M | ₩879B | 3.25% |
Chong Kun Dang Pharmaceutical185750 · KOSPI | ₩63,100 | +0.96% | ₩1.5B | ₩871B | 6.34% |
SK Chemicals285130 · KOSPI | ₩41,650 | +0.24% | ₩2.6B | ₩720B | 8.61% |
Boryung003850 · KOSPI | ₩8,310 | −0.24% | ₩384M | ₩713B | 4.12% |
Komipharm International041960 · KOSDAQ | ₩9,070 | +3.66% | ₩2.2B | ₩677B | 0.02% |
Myungin Pharm317450 · KOSPI | ₩40,100 | +1.01% | ₩557M | ₩585B | 0.68% |
Dong-A Pharmaceutical000640 · KOSPI | ₩86,900 | +0.70% | ₩493M | ₩585B | 9.45% |
JW Pharmaceutical001060 · KOSPI | ₩23,000 | −0.65% | ₩642M | ₩565B | 2.44% |
Shinpoong Pharmaceutical019170 · KOSPI | ₩8,350 | −0.71% | ₩2.1B | ₩438B | 0.39% |
GC005250 · KOSPI | ₩9,140 | +0.22% | ₩580M | ₩430B | 5.94% |
IL Dong Pharmaceutical249420 · KOSPI | ₩12,580 | +0.08% | ₩6.7B | ₩398B | 2.30% |
T&L340570 · KOSDAQ | ₩23,750 | −2.06% | ₩689M | ₩382B | 0.99% |
Bukwang Pharmaceutical IND003000 · KOSPI | ₩3,670 | −0.81% | ₩953M | ₩362B | 0.68% |
Dong-A ST170900 · KOSPI | ₩33,850 | −0.44% | ₩502M | ₩329B | 4.78% |
Kwangdong Pharmaceutical009290 · KOSPI | ₩6,240 | −1.11% | ₩1B | ₩311B | 0.80% |
Korea United Pharm033270 · KOSPI | ₩16,910 | +0.36% | ₩778M | ₩269B | 2.76% |
Samyang NC Chem482630 · KOSDAQ | ₩12,020 | −6.17% | ₩1.9B | ₩263B | — |
Huons Global084110 · KOSDAQ | ₩20,350 | −2.86% | ₩586M | ₩258B | 0.64% |
Samjin Pharmaceutical005500 · KOSPI | ₩19,250 | −0.62% | ₩613M | ₩256B | 2.05% |
Humedix200670 · KOSDAQ | ₩22,650 | −1.52% | ₩470M | ₩250B | 1.03% |
Ilsung IS003120 · KOSPI | ₩21,150 | −2.98% | ₩121M | ₩225B | 0.44% |
Hyundai Pharmaceutical004310 · KOSPI | ₩6,570 | −1.65% | ₩2.3B | ₩210B | 0.58% |
Huons243070 · KOSDAQ | ₩16,960 | −0.41% | ₩449M | ₩203B | 0.71% |
Daewon Pharmaceutical003220 · KOSPI | ₩8,680 | +12.73% | ₩13B | ₩195B | 0.90% |
Whanin Pharm016580 · KOSPI | ₩10,400 | −0.76% | ₩359M | ₩193B | 3.12% |
Union Korea Pharm080720 · KOSDAQ | ₩2,410 | 0.00% | ₩0 | ₩192B | — |
HEM Pharma376270 · KOSDAQ | ₩26,200 | +0.19% | ₩118M | ₩189B | — |
Vivozon Pharmaceutical082800 · KOSDAQ | ₩3,095 | +5.45% | ₩792M | ₩188B | — |
GC WellBeing234690 · KOSDAQ | ₩10,450 | −7.11% | ₩3.1B | ₩188B | 0.35% |
Chongkundang Holdings001630 · KOSPI | ₩35,600 | +0.56% | ₩100M | ₩178B | 4.29% |
Reyon Pharmaceutical102460 · KOSPI | ₩9,370 | +0.11% | ₩121M | ₩174B | 0.61% |
Dongsung Chemical102260 · KOSPI | ₩3,390 | −2.45% | ₩123M | ₩172B | 0.75% |
DAE HWA Pharm067080 · KOSDAQ | ₩9,170 | −1.93% | ₩239M | ₩171B | 0.08% |
Yungjin Pharm003520 · KOSPI | ₩931 | 0.00% | ₩399M | ₩170B | 0.49% |
JW Lifescience234080 · KOSPI | ₩10,510 | −0.76% | ₩160M | ₩166B | 0.72% |
Samil Pharmaceutical000520 · KOSPI | ₩7,650 | −0.52% | ₩242M | ₩166B | 0.67% |
Kyungdong Pharm011040 · KOSDAQ | ₩4,850 | −1.32% | ₩44M | ₩149B | 0.02% |
Daehan Pharmaceutical023910 · KOSDAQ | ₩24,750 | −1.00% | ₩130M | ₩149B | 1.35% |
Hana Pharm293480 · KOSPI | ₩8,070 | −1.94% | ₩221M | ₩143B | 0.63% |
Dongwha Pharm000020 · KOSPI | ₩5,100 | −1.16% | ₩520M | ₩142B | 0.61% |
Ilyang Pharmaceutical007570 · KOSPI | ₩6,960 | +0.72% | ₩96M | ₩133B | 0.43% |
Jeil Pharmaceutical271980 · KOSPI | ₩8,600 | −2.60% | ₩66M | ₩126B | 0.70% |
Ahn-Gook Pharmaceutical001540 · KOSDAQ | ₩9,450 | −0.42% | ₩526M | ₩123B | — |
Kyongbo Pharmaceutical214390 · KOSPI | ₩5,140 | −0.19% | ₩82M | ₩123B | 0.45% |
Pharmaresearch Bio217950 · KONEX | ₩29,250 | +0.17% | ₩11M | ₩122B | — |
Dongsung Pharmaceutical002210 · KOSPI | ₩1,196 | −2.21% | ₩68M | ₩116B | 0.00% |
Samsung Pharmaceutical001360 · KOSPI | ₩1,203 | −2.20% | ₩320M | ₩113B | 0.27% |
Handok002390 · KOSPI | ₩8,210 | −2.03% | ₩28M | ₩113B | 0.44% |
Kukjeon307750 · KOSDAQ | ₩2,055 | −0.96% | ₩308M | ₩111B | — |
Jeil Pharma Holdings002620 · KOSPI | ₩6,720 | −0.88% | ₩31M | ₩107B | 0.44% |
Optus Pharmaceutical131030 · KOSDAQ | ₩5,810 | −1.36% | ₩86M | ₩103B | — |
Icure Pharmaceutical Incorporation175250 · KOSDAQ | ₩1,530 | +11.60% | ₩1.3B | ₩94B | 0.20% |
DongKoo Bio & Pharma006620 · KOSDAQ | ₩3,250 | +3.83% | ₩226M | ₩93B | — |
High Tech Pharm106190 · KOSDAQ | ₩8,650 | −1.70% | ₩84M | ₩92B | — |
Prestige Biologics334970 · KOSDAQ | ₩1,158 | −2.93% | ₩226M | ₩90B | — |
Sam-A Pharm009300 · KOSDAQ | ₩13,630 | −0.15% | ₩131M | ₩87B | — |
Korea Pharma032300 · KOSDAQ | ₩7,770 | −0.38% | ₩135M | ₩85B | — |
Withus Pharmaceutical330350 · KOSDAQ | ₩6,370 | +0.16% | ₩840M | ₩84B | — |
Polaris AI Pharma041910 · KOSDAQ | ₩5,550 | −0.54% | ₩87M | ₩74B | — |
Yuhan Pref.000105 · KOSPI | ₩64,000 | +0.47% | ₩34M | ₩73B | — |
Daehan Nupharm054670 · KOSDAQ | ₩5,100 | −0.20% | ₩190M | ₩73B | — |
Shinil Pharmaceutical012790 · KOSDAQ | ₩6,090 | −2.87% | ₩125M | ₩73B | 0.39% |
Daebonglsco078140 · KOSDAQ | ₩6,550 | −1.36% | ₩79M | ₩73B | 2.30% |
SY Dong-A041930 · KOSDAQ | ₩4,730 | −0.42% | ₩83M | ₩72B | — |
Samik Pharm014950 · KOSDAQ | ₩7,080 | −8.29% | ₩7.3B | ₩71B | — |
Kukje Pharma002720 · KOSPI | ₩3,345 | −1.62% | ₩1.5B | ₩71B | 0.33% |
Ildong Holdings000230 · KOSPI | ₩5,660 | −1.22% | ₩112M | ₩65B | 0.32% |
CMG Pharmaceutical058820 · KOSDAQ | ₩4,170 | −4.58% | ₩363M | ₩62B | 0.03% |
Sinsin Pharmaceutical002800 · KOSDAQ | ₩3,975 | −1.49% | ₩161M | ₩60B | — |
Yuyu Pharma000220 · KOSPI | ₩3,650 | 0.00% | ₩219M | ₩57B | 0.12% |
Imgt456570 · KONEX | ₩10,900 | +2.16% | ₩610,370 | ₩57B | — |
GL Pharm Tech204840 · KOSDAQ | ₩3,570 | −0.28% | ₩149M | ₩55B | — |
SK Chemicals Pref.28513K · KOSPI | ₩23,700 | 0.00% | ₩74M | ₩50B | 1.29% |
CJ Bioscience311690 · KOSDAQ | ₩3,695 | +0.14% | ₩11M | ₩48B | — |
JIN Yang Pharmaceutical007370 · KOSDAQ | ₩3,405 | −1.45% | ₩99M | ₩48B | — |
Hwail Pharm061250 · KOSDAQ | ₩5,600 | −2.61% | ₩15M | ₩47B | — |
BL Pharmtech065170 · KOSDAQ | ₩1,681 | −6.14% | ₩412M | ₩47B | — |
Myungmoon Pharm017180 · KOSPI | ₩1,136 | −1.22% | ₩28M | ₩39B | 0.30% |
Kyung NAM Pharm053950 · KOSDAQ | ₩1,675 | −2.05% | ₩91M | ₩33B | — |
Korean Drug014570 · KOSDAQ | ₩2,810 | −1.06% | ₩34M | ₩31B | — |
Bcworldpharm200780 · KOSDAQ | ₩2,790 | −1.06% | ₩11M | ₩30B | 0.20% |
Korea Arlico Pharm260660 · KOSDAQ | ₩1,864 | −0.85% | ₩21M | ₩29B | — |
Tdspharm464280 · KOSDAQ | ₩4,500 | −3.43% | ₩22M | ₩25B | — |
Poongjeon Pharmacy298060 · KOSDAQ | ₩2,350 | −1.05% | ₩35M | ₩23B | — |
BASKHANBIOPharma354390 · KONEX | ₩3,215 | −8.01% | ₩3,215 | ₩23B | — |
Wooyang103840 · KOSDAQ | ₩1,352 | −4.52% | ₩29M | ₩22B | 0.52% |
Seoul Pharma018680 · KOSDAQ | ₩1,691 | −5.11% | ₩37M | ₩20B | — |
Telcon RF Pharmaceutical200230 · KOSDAQ | ₩1,992 | −1.63% | ₩14M | ₩19B | 0.20% |
Jeonjinbio110020 · KOSDAQ | ₩2,050 | 0.00% | ₩17M | ₩19B | — |
GC 2nd Pref.005257 · KOSPI | ₩16,980 | 0.00% | ₩2.3M | ₩14B | — |
ChoA Pharmaceutical034940 · KOSDAQ | ₩1,704 | −0.23% | ₩54M | ₩11B | — |
JW Pharmaceutical 2nd Pref.001067 · KOSPI | ₩49,600 | −0.20% | ₩1.1M | ₩10B | — |
Yuyu Pharma Pref.000225 · KOSPI | ₩3,385 | +1.96% | ₩44M | ₩7.7B | — |
JW Pharmaceutical Pref.001065 · KOSPI | ₩20,900 | −0.95% | ₩850,150 | ₩7.1B | — |
Kmpharmaceutical225430 · KOSDAQ | ₩698 | 0.00% | ₩0 | ₩4.5B | — |
Ilyang Pharmaceutical Pref.007575 · KOSPI | ₩6,830 | +0.15% | ₩1.5M | ₩3B | — |
Yuyu Pharma 2nd Pref.000227 · KOSPI | ₩7,530 | 0.00% | ₩368,890 | ₩2.4B | — |
Source: KRX statistical information